RESUMO
Among leaf-nosed bats (family Phyllostomidae), the genus Leptonycteris (subfamily Glossophaginae), contains three migratory and obligate nectar-dwelling species of great ecological and economic importance; the greater long-nosed bat L. nivalis, the lesser long-nosed bat L. yerbabuenae, and the southern long-nosed bat L. curasoae. According to the IUCN, the three species are categorized as 'vulnerable', 'endangered', and 'near threatened', respectively. In this study, we assembled and characterized in detail the mitochondrial genome of Leptonycteris spp. and examined the phylogenetic position of this genus in the family Phyllostomidae based on protein coding genes (PCGs). The mitogenomes of L. nivalis, L. curasoae, and L. yerbabuenae are 16,708, 16,758, and 16,729 bp in length and each encode 13 PCGs, 22 transfer RNA genes, 2 rRNA genes, and a putative control region (CR). Mitochondrial gene order is identical to that reported before for the family Phyllostomidae. All tRNAs exhibit a 'cloverleaf' secondary structure, except tRNA-Serine-1 that is missing the DHU arm in the three species. All PCGs are exposed to purifying selection with atp8 experiencing the most relaxed purifying selection as the ω ratio was higher for this gene compared to the other PCGs in each species. The CR of each species contains three functional domains: extended termination associated sequence (ETAS), Central, and conserved sequence block domain (CSB). A phylomitogenomic analysis revealed that Leptonycteris is monophyletic and most closely related to the genus Glossophaga. The analysis also supported the monophyly of the family Glossophaginae in the speciose family Phyllostomidae. The mitochondria characterization of these species provides relevant information to develop molecular markers for conservation purposes.
Assuntos
Quirópteros , Genoma Mitocondrial , Animais , Filogenia , Quirópteros/genética , Néctar de Plantas , Genômica , Mitocôndrias/genética , Genoma Mitocondrial/genética , RNA de Transferência/genéticaRESUMO
Resumen Se presenta el caso de una mujer de 67 años, con antecedentes de hipertensión arterial y obesidad, que acudió a urgencias por tos, fatiga, fiebre y disnea. Durante la monitorización se documentó elevación del segmento ST anterolateral e inferior y elevación de troponina; la arteriografía coronaria no evidenció lesiones significativas; en el ventriculograma y en el ecocardiograma transtorácico se documentó acinesia apical. Se confirmó RT-PCR positiva para SARS-CoV-2; se consideró como diagnóstico síndrome de takotsubo.
Abstract A 67-years-old woman with hypertension, obesity as previous diseases, presented to the emergency department due to cough, fatigue, fever, and dyspnea. ST-segment elevation was visualized during monitoring, troponin was positive, the coronary angiography was negative; the ventriculogram and transthoracic echocardiogram documented apical akinesia. The RT-PCR was positive for SARS CoV-2; the diagnosis was takotsubo-syndrome.
RESUMO
Despite substantial literature surrounding how people process and perceive faces, there is very little research investigating how people evaluate their own faces. We examined how gender, body mass, race, age, and sexual orientation were linked to people's satisfaction with the appearance of their eyes, nose, facial shape, and face overall among 11,620 adults recruited via Mechanical Turk. Most people mostly or definitely agreed they were happy with their facial appearance. There were notable racial differences, with Asian participants tending to report greater dissatisfaction. For example, only 66% of Asian women and 60% of Asian men mostly or definitely agreed that they were happy with the appearance of their eyes, which was lower than other racial groups. BMI and age were not strongly associated with face satisfaction. Sexual minority men were less satisfied than heterosexual men. About one in four gay and bisexual men, compared to only one in seven heterosexual men, reported dissatisfaction with their overall facial appearance. Men and women with poorer face image engaged in more appearance surveillance, more strongly internalized the thin-ideal, and perceived stronger sociocultural pressures from peers, parents, and media. The current study highlights important sociocultural and demographic factors tied to poorer face image.
Assuntos
Imagem Corporal , Minorias Sexuais e de Gênero , Adulto , Imagem Corporal/psicologia , Demografia , Feminino , Heterossexualidade , Humanos , Masculino , Satisfação PessoalRESUMO
We present the case of a 61 years old man with hypothyroidism, hypertension, type 2 diabetes mellitus, and ischemic cardiopathy, who was admitted with a diagnosis of non-ST elevation myocardial infarction. The coronary angiography describes coronary ectasia with giant aneurysm and slow flow in the right coronary and aneurysm with slow flow anterior descending coronary. The echocardiogram shows contractility disorders with severely decreased left ventricular ejection fraction (20%) despite optimal medical management. This case presents a patient with ischemic heart disease and advanced heart failure secondary to coronary aneurysm, the proposed optimal treatment was a heart transplant given the disease's progression.
RESUMO
BACKGROUND AND AIMS: Thyroid storm and severe thyrotoxicosis remain among the most frequent endocrine emergencies, and first-line hyperthyroidism treatment is not always an option. Since the first report in 1970, plasmapheresis is a second-line treatment for severe or otherwise untreatable thyrotoxicosis when rapid euthyroidism is desired. METHODS: We present a retrospective study of the experience in treating thyrotoxicosis with plasmapheresis between 2012 and 2020 in two specialized centers in Colombia. We register the demographic and clinical characteristic and compare the thyroid hormones and other biochemical measurements before and after treatment. RESULTS: Data from 19 patients was obtained, 58% female with a median age of 35 years (IQR 23.5), and most of them with Graves' disease. The most frequent indication for plasmapheresis was thyroid storm. A median of 4 (IQR 2) sessions lead to a significant reduction in FT4 (P .0001) and TT3 (P < .0003) with a nonsignificant decrease in beta-blocker (P .7353) dose, no change in hepatic enzymes, and no adverse events. After plasmapheresis, thyroidectomy was performed in 10 patients. CONCLUSIONS: Plasmapheresis is an effective and safe treatment option for reducing circulating thyroid hormones in severe thyrotoxicosis when other forms of treatment are contraindicated or in case of urgent thyroid and non-thyroid surgery. It is limited by its cost and the need for highly specialized resources.
Assuntos
Plasmaferese/métodos , Tireotoxicose/terapia , Adolescente , Adulto , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Plasmaferese/efeitos adversos , Propranolol/uso terapêutico , Estudos Retrospectivos , Hormônios Tireóideos/sangue , Tireotoxicose/sangue , Adulto JovemRESUMO
Resumen El origen anómalo de la arteria coronaria izquierda desde la arteria pulmonar o, por su sigla en inglés, síndrome de ALCAPA (Anomalous origin of the Left Coronary Artery from the Pulmonary Artery), también conocido como síndrome Bland-White-Garland es una rara cardiopatía congénita; sin embargo, es una de las causas más comunes de falla cardiaca, isquemia e infarto de miocardio en niños, que, en ausencia de tratamiento, alcanza una tasa de mortalidad del 35 al 85 % en el primer año de vida. Hay dos tipos de síndrome de ALCAPA, aquel que se presenta en infantes y el que ocurre en adultos. El segundo tipo es raro y puede manifestarse como infarto de miocardio, disfunción ventricular izquierda e insuficiencia mitral, o isquemia silente que podría llevar a muerte súbita. Se presenta el caso de una paciente de 30 años, con cardiopatía dilatada y disfunción ventricular severa, secundaria a síndrome de ALCAPA, y el caso de un paciente de 61 años con cuadro de dolor torácico en quien se documentó el mismo síndrome.
Abstract The anomalous origin of the left coronary artery from the pulmonary artery or its acronym ALCAPA syndrome (Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery), also known as Blande-Whitee-Garland syndrome, is a rare congenital heart disease. However, one of the most common causes of heart failure, ischemia and myocardial infarction in children, which in the absence of treatment, reaches a mortality rate of 35 to 85% in the first year of life. There are two types of ALCAPA syndrome, that occurs in infants and adults. The presentation of the second type is rare and can manifest as myocardial infarction, left ventricular dysfunction and mitral insufficiency, or silent ischemia that could lead to sudden death. We present the case of a 30-year-old patient with dilated cardiomyopathy and severe ventricular dysfunction, secondary to the ALCAPA syndrome, another case of a 61-year-old patient with chest pain where the mentioned syndrome was documented.
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Síndrome de Bland-White-Garland , Disfunção Ventricular , Vasos Coronários , Cardiopatias Congênitas , Insuficiência da Valva MitralRESUMO
Thyroid nodules (TN) are more frequently identified with the use of thyroid ultrasonography, and they have a low risk of malignancy. Ultrasonographic features have been established that increase the probability of being faced with thyroid carcinoma; however, individually, these characteristics do not perform adequately in the diagnosis of malignancy, limiting their usefulness when indicating cytological studies by means of fine-needle aspiration (FNC). This situation motivated the development of risk stratification systems for thyroid nodules, which unified their ultrasound characteristics, with the aim of establishing risk categories, standardizing the preparation of reports, and providing the clinician with useful tools to define the surveillance option or form invasive studies. The objective of this review is to compare the different systems developed by some scientific societies for the stratification of thyroid nodules, with respect to their predictive capacities for malignancy, their operational characteristics for diagnosis, and, to suggest recommendations for the implementation of these systems, placing emphasis on those with the best ability to reduce the performance of unnecessary invasive studies and to guide decision-making in the face of undetermined cytological results.
RESUMO
A non-planned pregnancy in a patient with type 1 diabetes with ocular complications, was treated with degludec from pre-conception stages until the postpartum is reported. The newborn was healthy without any congenital abnormalities; however, due to respiratory distress required neonatal intensive care unit.
RESUMO
Resumen: el feocromocitoma es una enfermedad poco frecuente, correspondiente a un tumor derivadode las células cromafines, originado en la médula de la glándula suprarrenal. Cuando este tumor se origina en los paraganglios el término correcto es paraganglioma. Las manifestaciones clínicas son variables y secundarias a la masa tumoral o a la producción exagerada de catecolaminas. Los síntomas originados por el crecimiento de la masa tumoral incluyen dolor abdominal, malestar epigástrico, obstrucción de estructuras cercanas como la vía biliar y los uréteres, y, cuando está localizado en otros sitios como el mediastino, disnea. Los síntomas secundarios a la hiperproducción de catecolaminas son diaforesis, palpitaciones, cefalea, crisis hipertensivas, hipertensión sostenida, constipación, náuseas, vómito y, en la forma más exagerada, crisis catecolaminérgicas. El diagnóstico se realiza mediante la medición de metanefrinas libres en orina de 24 horas o en plasma, y como alternativa se puede realizar medición de catecolaminas en orina de 24 horas. La medición de ácido vanilmandélico es poco sensible, lo mismo que la medición de catecolaminas en plasma, la cual no es recomendada. El tratamiento de esta enfermedad es quirúrgico. En aquellos pacientes con feocromocitomamaligno o paraganglioma se puede realizar una estrategia de observación activa y en quienes tengan progresión de la enfermedad el uso de quimioterapia o, según el grado de compromiso, el uso de metayodobencilguanidina marcada con yodo-131 es la terapia de elección. El uso de terapia molecular diana utilizando inhibidores de tirosina quinasa es un área de investigación activa.
Abstract: Pheochromocytoma is a rare disease, corresponding to a tumor originated in the chromaphincells, and located in the adrenal medulla. When the tumor is located in the paraganglia the appropriate term is paraganglioma. Clinical manifestations are variable and secondary to the tumoral local extension or to the overproduction of catecholamines. Symptoms secondary to local growth of the tumor includes abdominal pain, epigastric discomfort, obstruction of nearby structures such as biliary tree and ureters, and when is located in other regions such as the mediastinum, dyspnea. Symptoms secondary to overproduction of catecholamines are diaphoresis, headache, hypertensive emergencies, sustained hypertension, constipation, nausea, vomiting and, in the most extreme form, catecholaminergic crisis. Diagnosis is based on the measurement of free plasmatic or urinary metanephrines.As an alternative can be used 24 hours urinary catecholamines. The detection of vanillylmandelic acid and plasma catecholamines has poor sensibility and is no longer recommended. The treatment of this entity is surgical resection. In those patients with malignant pheochromocytoma or paraganglioma an observation and watch strategy can be used. If disease progression is detected, the use of chemotherapy or iodine-131-labeled meta-iodobenzylguanidine, according to the severity of compromise, is the next step. The use of targeted molecular therapies using tyrosine kinase inhibitoris an area under active research.
Assuntos
Humanos , Carcinoma Neuroendócrino , Catecolaminas , Metanefrina , Paraganglioma , FeocromocitomaRESUMO
Objetivo: Describir la experiencia de 14 años del Instituto Nacional de Cancerología de Colombia en el tratamiento de los estados avanzados de cáncer epitelial de ovario. Métodos: Estudio observacional retrospectivo tipo serie de casos que incluyó pacientes con cáncer epitelial de ovario en estados III y IV, las cuales fueron llevadas a tratamiento primario en el Instituto Nacional de Cancerología entre el 1 de enero de 1997 y el 31 de diciembre de 2011. Resultados: Se identificación 119 pacientes para el período de interés. Con una mediana de edad de 56 años, la mayoría de pacientes presentó compromiso en el estado funcional (63,9%) e hipoalbuminemia (82,4%). El tipo histológico más frecuente fue el adenocarcinoma seroso (62,2%), y el grado histológico mal diferenciado ocurrió en el 63,3% de los casos. Un 94,1% de los pacientes presentó compromiso de superficies peritoneales, con afectación de abdomen superior en un 38,7% y enfermedad extraabdominal un 29,4%. Se tuvo como intención de tratamiento la cirugía primaria más quimioterapia adyuvante en el 89,1% de las pacientes, logrando una citorreducción óptima en el 25,2% de los casos. El 29% presentó progresión durante el tratamiento y en un 57% se registró recaída. La mediana de supervivencia libre de enfermedad fue de 16,61 meses, y la de supervivencia global, de 28,93 meses. Conclusiones: Las pacientes con cáncer epitelial de ovario avanzado de nuestro medio se presentan con alta carga tumoral y con un comportamiento agresivo de la enfermedad reflejado en un pobre resultado oncológico.
Objective: To describe fourteen years of experience of in the treatment of advanced stages of epithelial ovarian cancer in the National Cancer Institute of Colombia. Methods: A retrospective observational case series including patients with epithelial ovarian cancer in stages III and IV, who received primary treatment in National Cancer Institute of Colombia between January 1st, 1997 and December 31th, 2011. Results: A total of 119 patients were identified durin the study period. With a median age of 56 years, most patients showed functional status compromise (63.9%) and hypolbuminemia (82.4%). The most common histological type was serous adenocarcinoma (62.2%) and there was poorly differentiated histological grade in 63.3% of cases. Almost all (94.1%) patients had peritoneal surfaces compromise with involvement of the upper abdomen in 38.7% and extra-abdominal disease in 29.4%. Treatment with primary surgery plus adjuvant chemotherapy was performed on 89.1%, achieving optimal cytoreduction in 25.2%; 29% of cases showed progression during treatment, and 57% of them relapsed. The median disease-free survival was 16.61 months, and the overall survival was 28.93 months. Conclusions: In our setting, patients with advanced epithelial ovarian cancer have a high tumor burden and aggressive behavior of the disease, reflected in a poor oncological outcome.
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Ovário , Terapêutica , Quimioterapia Adjuvante , Carcinoma Epitelial do Ovário , Sobrevida , Comportamento , Adenocarcinoma , Tratamento Primário , Registros , Hipoalbuminemia , NeoplasiasRESUMO
Diagnosing systemic lupus erythematosus (SLE) can be challenging as laboratory screening methods, although sensitive, lack specificity. The poor specificity of autoimmune testing produces more false positive results than true positive results. False positive results can cause stress to patients without autoimmune disease and require unnecessary rheumatology consultation to rule out disease. Our objective was to evaluate two screening assays to reduce the number of false positives while maintaining high sensitivity. In this study, we evaluated two immunoassays, the AtheNA Multi-Lyte II ANA System and QUANTA Lite ANA ELISA, to screen patients for SLE. All positive screening results were compared to immunoflourescent ANA testing using theHEp-2000 ANA System. A chart review was performed on all patients tested to determine clinical diagnosis of SLE. The QuantaLite ANA ELISA produced significantly more false positive results than the AtheNA Multi-Lyte II Test System when screening for SLE in our patient population.
Assuntos
Imunoensaio/métodos , Lúpus Eritematoso Sistêmico/diagnóstico , Ensaio de Imunoadsorção Enzimática/métodos , Humanos , Valor Preditivo dos Testes , Sensibilidade e EspecificidadeRESUMO
The human gastrointestinal mucosa is exposed to a diverse normal microflora and dietary Ags and is a common site of entry for pathogens. The mucosal immune system must respond to these diverse signals with either the initiation of immunity or tolerance. APCs are important accessory cells that modulate T cell responses which initiate and maintain adaptive immunity. The ability of APCs to communicate with CD4+ T cells is largely dependent on the expression of class II MHC molecules by the APCs. Using immunohistochemistry, confocal microscopy, and flow cytometry, we demonstrate that alpha-smooth muscle actin(+), CD90+ subepithelial myofibroblasts (stromal cells) constitutively express class II MHC molecules in normal colonic mucosa and that they are distinct from professional APCs such as macrophages and dendritic cells. Primary isolates of human colonic myofibroblasts (CMFs) cultured in vitro were able to stimulate allogeneic CD4+ T cell proliferation. This process was dependent on class II MHC and CD80/86 costimulatory molecule expression by the myofibroblasts. We also demonstrate that CMFs, engineered to express a specific DR4 allele, can process and present human serum albumin to a human serum albumin-specific and DR4 allele-restricted T cell hybridoma. These studies characterize a novel cell phenotype which, due to its strategic location and class II MHC expression, may be involved in capture of Ags that cross the epithelial barrier and present them to lamina propria CD4+ T cells. Thus, human CMFs may be important in regulating local immunity in the colon.
Assuntos
Células Apresentadoras de Antígenos/imunologia , Antígenos de Histocompatibilidade Classe II/imunologia , Mucosa Intestinal/citologia , Mucosa Intestinal/imunologia , Mioblastos de Músculo Liso/imunologia , Actinas/análise , Apresentação de Antígeno , Antígeno B7-1/análise , Antígeno B7-2/análise , Linfócitos T CD4-Positivos/imunologia , Proliferação de Células , Técnicas de Cocultura , Colo/química , Colo/citologia , Colo/imunologia , Epitélio/química , Epitélio/imunologia , Fibroblastos/química , Fibroblastos/imunologia , Antígenos HLA-DR/análise , Antígenos de Histocompatibilidade Classe II/análise , Humanos , Imuno-Histoquímica , Interferon gama/farmacologia , Leucócitos Mononucleares/imunologia , Microscopia Confocal , Mucosa/imunologia , Mioblastos de Músculo Liso/química , Mioblastos de Músculo Liso/efeitos dos fármacos , Células Estromais/química , Células Estromais/imunologia , Antígenos Thy-1/análiseRESUMO
La enfermedad de Graves se caracteriza por hipertiroidismo, bocio difuso, oftalmopatía yalgunas veces dermopatía. Aunque el diagnóstico es fácil, una vez las pruebas diagnósticas losugieren, el clínico necesita estar atento a la presentación heterogénea de la enfermedad,especialmente en el paciente anciano. Debido a que la morbilidad puede asociarse aún conformas leves de hipertiroidismo, se necesita de tratamientos que restauren el eutiroidismo.Aunque todos los tratamientos son efectivos, se deben discutir los riesgos y beneficios de cadaaproximación. Esta revisión busca orientar al clínico en el diagnóstico y tratamiento del pacientecon hipertiroidismo
Assuntos
Adulto , Doença de Graves , Hipertireoidismo , Tireotoxicose , Síndromes do Eutireóideo DoenteRESUMO
CD74 is known as the major histocompatibility complex (MHC) class II-associated invariant chain (Ii) that regulates the cell biology and functions of MHC class II molecules. Class II MHC and Ii expression was believed to be restricted to classical antigen-presenting cells (APC); however, during inflammation, other cell types, including mucosal epithelial cells, have also been reported to express class II MHC molecules. Given the importance of Ii in the biology of class II MHC, we sought to examine the expression of Ii by gastric epithelial cells (GEC) to determine whether class II MHC molecules in these nonconventional APC cells were under the control of Ii and to further support the role that these cells may play in local immune and inflammatory responses during Helicobacter pylori infection. Thus we examined the expression of Ii on GEC from human biopsy samples and then confirmed this observation using independent methods on several GEC lines. The mRNA for Ii was detected by RT-PCR, and the various protein isoforms were also detected. Interestingly, these cells have a high level expression of surface Ii, which is polarized to the apical surface. These studies are the first to demonstrate the constitutive expression of Ii by human GEC.
Assuntos
Células Apresentadoras de Antígenos/metabolismo , Antígenos CD/biossíntese , Antígenos de Diferenciação de Linfócitos B/biossíntese , Células Epiteliais/metabolismo , Mucosa Gástrica/metabolismo , Antígenos de Histocompatibilidade Classe II/biossíntese , Antígenos CD/genética , Antígenos de Diferenciação de Linfócitos B/genética , Linhagem Celular , Mucosa Gástrica/citologia , Gastrite/metabolismo , Gastrite/microbiologia , Infecções por Helicobacter/metabolismo , Helicobacter pylori , Antígenos de Histocompatibilidade Classe II/genética , Humanos , Isoformas de Proteínas/biossíntese , Isoformas de Proteínas/genética , RNA Mensageiro/biossíntese , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
The pathogenesis associated with Helicobacter pylori infection requires consistent contact with the gastric epithelium. Although several cell surface receptors have been suggested to play a role in adhesion, the bacterium-host interactions that elicit host responses are not well defined. This study investigated the interaction of H. pylori with the class II major histocompatibility complex (MHC)-associated invariant chain (Ii; CD74), which was found to be highly expressed by gastric epithelial cells. Bacterial binding was increased when CD74 surface expression was increased by gamma interferon (IFN-gamma) treatment or by fibroblast cells transfected with CD74, while binding was decreased by CD74 blocking antibodies, enzyme cleavage of CD74, and CD74-coated bacteria. H. pylori was also shown to bind directly to affinity-purified CD74 in the absence of class II MHC. Cross-linking of CD74 and the engagement of CD74 were verified to stimulate IL-8 production by unrelated cell lines expressing CD74 in the absence of class II MHC. Increased CD74 expression by cells increased IL-8 production in response to H. pylori, and agents that block CD74 decreased these responses. The binding of H. pylori to CD74 presents a novel insight into an initial interaction of H. pylori with the gastric epithelium that leads to upregulation of inflammatory responses.